Metadata record for the article: Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer

Summary This metadata record provides details of the data supporting the claims of the related article: “Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer”. The related study evaluated factors associated with treatment-related amenorrhea (TRA) using logistic regression. Type of data: clinical data Subject of data: Homo sapiens Population characteristics: women diagnosed with breast cancer at age ≤40 Recruitment: Participants were enrolled from 12 sites in the United States and Canada from 2006-2016 within six months of diagnosis. Those who were able to respond to questionnaires in English were eligible. Trial registration number: NCT01468246 Data access The final analyses for the related study are contained in the 52 .csv files listed in the attached file ‘underlying_data_files_list.csv’. These files are not publicly available as the IRB-approved research protocol specified that all data must collected, coded, and stored at the Dana-Farber Cancer Institute and be limited-access and password-protected in the Partners system, in order to protect the identity of respondents. Requests can be made to share data privately. However, any data sharing will require a formal data transfer agreement between the Dana-Farber Cancer Institute and the other party. Requests to this effect should be directed to the corresponding author. Corresponding author(s) for this study Ann H. Partridge, MD, MPH, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215. Telephone: 617-632-3800. Fax: 617-632-1930. Email: ann_partridge@dfci.harvard.edu Study approval IRB approval for the study was obtained through Dana-Farber/Harvard Cancer Center (DF/HCC) and other participating centres.